CIM
PBYI icon

CenturyLink Investment Management’s Puma Biotechnology PBYI Stock Holding History

CenturyLink Investment Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,761
Closed -$322K – 284
2015
Q2 		$322K Buy
2,761
+320
+13% +$58K 0.11% 206
2015
Q1 		$576K Sell
2,441
-850
-26% -$182K 0.19% 165
2014
Q4 		$623K Buy
3,291
+1,472
+81% +$327K 0.18% 164
2014
Q3 		$434K Sell
1,819
-1,800
-50% -$370K 0.15% 179
2014
Q2 		$239K Buy
3,619
+1,695
+88% +$121K 0.07% 216
2014
Q1 		$200K Buy
+1,924
New +$226K 0.06% 220

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return